<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>377-NEUROLEPTICS-THAT-TEND-TO-INDUCE-TORSADES-DE-POINTES.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="NEUROLEPTICS THAT TEND TO INDUCE TORSADES DE POINTES" code="N05A-002" /></DRUG1>
<DRUG2>
<CLASS name="SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES" code="C01-N05" /></DRUG2>
<DESCRIPTION>Increased risk of ventricular arrhythmias, especially of torsades de pointes</DESCRIPTION>
<SEVERITY>Contraindication</SEVERITY>
<COMMENT>-with citalopram, domperidone, escitalopram, hydroxyzine and piperaquine</COMMENT>
</INTERACTION>
</INTERACTIONS>
